Merck & Co., Inc.
MRK
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vacciā¦ read more
Healthcare
Drug ManufacturersāGeneral
48 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$109.19
Price-1.21%
-$1.34
1Y
Price
Market Cap
$274.417b
Large
Price/Earnings 3y Avg5y Avg
14.4x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+47.1%
EBITDA Margin+33.5%
Net Profit Margin+39.6%
Free Cash Flow Margin+47.1%
EBITDA Margin+33.5%
Net Profit Margin+39.6%
Free Cash Flow MarginRevenue
$64.235b
+0.1%
1y CAGR+2.8%
3y CAGR+7.5%
5y CAGREarnings
$19.034b
+11.2%
1y CAGR+1501.1%
3y CAGR+1128.6%
5y CAGREPS
$7.57
+12.3%
1y CAGR+1543.0%
3y CAGR+1160.0%
5y CAGRBook Value
$51.907b
$129.546b
Assets$77.639b
Liabilities$41.374b
DebtDebt to Assets
31.9%
1.5x
Debt to EBITDAFree Cash Flow
$13.049b
-27.9%
1y CAGR+10.7%
3y CAGR+21.1%
5y CAGRNo items found.
Press Releases
Statements and updates from the company